Results 181 to 190 of about 20,881 (221)
Transmission and Colonization of Pneumocystis jirovecii
Journal of Fungi (Basel, Switzerland), 2021 Pneumocystis spp. was discovered in 1909 and was classified as a fungus in 1988. The species that infects humans is called P. jirovecii and important characteristics of its genome have recently been discovered. Important advances have been made to understand P.
Zulma Vanessa Rueda
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2010
The ascomycete fungus Pneumocystis jirovecii (previously called Pneumocystis carinii) is the cause of pneumocystis pneumonia (PCP) in humans, which occurs largely among people with impaired CD4+ T-lymphocyte function or numbers, e.g those infected with HIV, or organ transplant recipients taking therapeutic immunosuppressive agents.
Robert F. Miller, Laurence Huang
openaire +2 more sources
The ascomycete fungus Pneumocystis jirovecii (previously called Pneumocystis carinii) is the cause of pneumocystis pneumonia (PCP) in humans, which occurs largely among people with impaired CD4+ T-lymphocyte function or numbers, e.g those infected with HIV, or organ transplant recipients taking therapeutic immunosuppressive agents.
Robert F. Miller, Laurence Huang
openaire +2 more sources
Pneumocystis jirovecii genotypes and granulomatous pneumocystosis
Médecine et Maladies Infectieuses, 2006This study describes the initial data concerning molecular typing of Pneumocystis jirovecii in a patient having developed granulomatous Pneumocystis pneumonia (PCP). Three types, B(1)a(3), B(1)a(4), B(1)b(2), were identified. All three had been described in reports concerning patients with common diffuse alveolar PCP.
Totet, A. +5 more
openaire +3 more sources
Pneumocystis jirovecii Pneumonia
2020The life cycle of Pneumocystis jirovecii is complicated. It tries to find a damaged immune system to replicate, leading to life-threatening complications. With the treatment of immunosuppressive drugs, Pneumocystis jirovecii pneumonia has become a common opportunistic infection in non-AIDS populations. A CD4+ lymphocyte count of
Jing Feng +4 more
openaire +1 more source
Pneumocystis jirovecii and Pneumocystosis
2017Pneumocystis jirovecii pneumonia (PcP or pneumocystosis) remains a major cause of respiratory illness among immunocompromised patients, especially those infected with the human immunodeficiency virus (HIV). P. jirovecii infection has also been detected in healthy individuals and people with chronic lung diseases, raising the possibility that the ...
Olga Matos +2 more
openaire +1 more source
Pneumocystis jirovecii and cystic fibrosis in France
Scandinavian Journal of Infectious Diseases, 2010We retrospectively investigated 76 patients with cystic fibrosis for the presence of Pneumocystis jirovecii, by performing real-time PCR and nested-PCR assays on 146 archival sputum specimens. P. jirovecii was detected in only 1 patient (1.3%) showing that in our region (Brest, France), the fungus is rarely involved in pulmonary colonization in ...
Solène Le, Gal +6 more
openaire +2 more sources
Pneumocystis jirovecii (carinii)
2015This chapter cites Pneumocystis jirovecii (PJP), formerly known as Pneumocystis carinii, as an opportunistic pathogen that causes pneumonia in the immunocompromised individual. It explains how the disease caused by PJP occurs when both cellular and humoral immunity are impaired.
Shelley A. Gilroy, Nicholas J. Bennett
openaire +1 more source
Pneumocystis jirovecii: a review with a focus on prevention and treatment
Expert Opinion on Pharmacotherapy, 2021Dima Kabbani +2 more
exaly